Admission hyperglycemiaas a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: Data from the Spanish SEMI-COVID-19 Registry.
Conclusion: Admission hyperglycemiais a strong predictor of all-cause mortality in non-critically hospitalized COVID-19 patients regardless ofprior history of diabetes. Key Messages:Admission Hyperglycemia is a stronger and independent risk factor for mortality in COVID-19.Screening for hyperglycemia, in patients without diabetes, and early treatment of hyperglycemia shouldbe mandatory in the management of patients hospitalized with COVID-19.Admission hyperglycemia should not be overlooked in all patients regardless prior history of diabetes.
PMID: 33063540 [PubMed - as supplied by publisher]
Source: Annals of Medicine - Category: Internal Medicine Tags: Ann Med Source Type: research
More News: Coronavirus | COVID-19 | Diabetes | Endocrinology | Hypertension | Internal Medicine | Spain Health | Study